1. Home
  2. WETH vs CYCN Comparison

WETH vs CYCN Comparison

Compare WETH & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.36

Market Cap

17.5M

Sector

N/A

ML Signal

HOLD

Logo Cyclerion Therapeutics Inc.

CYCN

Cyclerion Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

16.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
CYCN
Founded
1992
2018
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
16.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
WETH
CYCN
Price
$1.36
$3.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
161.5K
22.1K
Earning Date
04-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
15.38
N/A
EPS
0.32
N/A
Revenue
$45,136,818.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.13
N/A
Revenue Growth
6.76
N/A
52 Week Low
$0.78
$1.03
52 Week High
$3.68
$8.48

Technical Indicators

Market Signals
Indicator
WETH
CYCN
Relative Strength Index (RSI) 54.60 62.72
Support Level $1.30 $2.93
Resistance Level $1.48 $3.97
Average True Range (ATR) 0.12 0.23
MACD 0.02 -0.00
Stochastic Oscillator 84.06 60.47

Price Performance

Historical Comparison
WETH
CYCN

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a business of research and development, manufacturing, and distribution of touchscreen displays to customers both in the PRC and overseas. The touchscreen products, which are manufactured by the Company, are mainly for use in financial terminals, automotive, Point of Sales, gaming, lottery, medical, Human-Machine Interface (HMI), and other specialized industries. The company sells touchscreen products both domestically in China and internationally, covering areas in Mainland China, including but not limited to the eastern, southern, northern, and southwest regions of Mainland China, Taiwan, South Korea, Germany, and other countries.

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. The company focuses on enabling the full therapeutic potential of next-generation sGC stimulators and neuropsychiatric diseases. Its pipeline products include Olinciguat, Praliciguat, and others.

Share on Social Networks: